From Physics to Precision Medicine: Moritz Gerstung Reflects on How AI Is Transforming Cancer Genomics

Moritz Gerstung (EMBL-EBI Group Leader, 2015-2021) speaks with Angus Lamond (EMBL Group Leader, 1987-1995), discussing his transition from physics to computational biology, driven by the complexities of biological systems.

He highlights his work at EMBL-EBI, which focused on cancer genomes and tumour dynamics using next-generation sequencing and AI tools. Moritz emphasised the importance of open data access, citing EMBL's role in storing and sharing genomes. He noted the significant impact of AI in cancer research, including the analysis of tumor microscopy and electronic health records. Moritz also discussed the challenges and potential of AI in healthcare, stressing the need for regulatory frameworks and critical assessment.

This conversation was recorded in July 2025.

Alumni Chat contributors are members of the European Molecular Biology Laboratory (EMBL) community. The opinions expressed are their own and are not necessarily representative of the views of EMBL or any other party. The mere appearance of video content on the EMBL Alumni RSS account does not constitute an endorsement by EMBL.

Audio Production and Editing: EMBL Alumni Relations

Content and Interviews: Angus Lamond and Thomas Vaccari

Music: Eco Technology by Aleksey Chistilin from Pixabay

Thanks to: EMBL Audiovisual and EMBL Design

Sponsored by: EMBLEM

© European Molecular Biology Laboratory (EMBL)